Table of contents

  • Preliminary material 
    • Title and verso pages
    • Foreword
    • Contents
    • Acknowledgments
    • Abbreviations
    • Symbols
    • Executive summary 3
  • Body section
    1. Overview 
      • 1.1 Background
      • 1.2 The BEACH program
      • 1.3 Issues when using BEACH data with other national data
      • 1.4 Access to BEACH data
    2. Methods 
      • 2.1 Sampling methods
      • 2.2 Recruitment methods
      • 2.3 Data elements
      • 2.4 The BEACH relational database
      • 2.5 Supplementary Analysis of Nominated Data
      • 2.6 Statistical methods
      • 2.7 Classification of data
      • 2.8 Quality assurance
      • 2.9 Validity and reliability
      • 2.10 Extrapolated national estimates
    3. The sample
      • 3.1 Response rate
      • 3.2 Representativeness of the GP sample
      • 3.3 Weighting the data
      • 3.4 Representativeness of the final encounter sample
      • 3.5 The weighted data set
    4. The participating GPs
      • 4.1 Characteristics of the GP participants
      • 4.2 Computer use at GP practices
      • 4.3 Changes in characteristics of the GPs over the decade 1999–00 to 2008–09
    5. The encounters 
      • 5.1 Content of the encounters
      • 5.2 Encounter type
      • 5.3 Consultation length
      • 5.4 Changes in the encounters over the decade 1999–00 to 2008–09
    6. The patients 
      • 6.1 Age–sex distribution of patients at encounter
      • 6.2 Other patient characteristics
      • 6.3 Patient reasons for encounter
      • 6.4 Changes in patients and reasons for encounter over the decade 1999–00 to 2008–09
    7. Problems managed 
      • 7.1 Number of problems managed at encounter
      • 7.2 Problems managed by ICPC-2 chapter
      • 7.3 Problems managed by ICPC-2 component
      • 7.4 Most frequently managed problems
      • 7.5 Most common new problems
      • 7.6 Most frequently managed chronic problems
      • 7.7 Work-related problems managed
      • 7.8 Management of lipid problems in 2008–09
      • 7.9 Changes in problems managed over the decade 1999–00 to 2008–09
    8. Overview of management
      • 8.1 Changes in management over the decade 1999–00 to 2008–09
    9. Medications 
      • 9.1 Source of medications
      • 9.2 Prescribed medications
      • 9.3 Medications supplied by GPs
      • 9.4 Medications advised for over-the-counter purchase
      • 9.5 Opioids prescribed or supplied in 2008–09
      • 9.6 Changes in medications over the decade 1999–00 to 2008–09
    10. Other treatments 
      • 10.1 Number of other treatments
      • 10.2 Clinical treatments
      • 10.3 Procedural treatments
      • 10.4 Changes in other treatments over the decade 1999–00 to 2008–09
    11. Referrals and admissions 
      • 11.1 Number of referrals and admissions
      • 11.2 Most frequent referrals
      • 11.3 Problems most often referred
      • 11.4 Changes in referrals over the decade 1999–00 to 2008–09
    12. Investigations 
      • 12.1 Number of investigations
      • 12.2 Pathology ordering
      • 12.3 Imaging ordering
      • 12.4 Other investigations
      • 12.5 Full blood counts ordered in 2008–09
      • 12.6 Changes in investigations over the decade 1999–00 to 2008–09
    13. Practice nurse activity 
      • 13.1 Practice nurse Medicare claims and practice nurse activity
      • 13.2 Problems managed with practice nurse involvement
      • 13.3 Discussion
      • 13.4 Changes in practice nurse activity, 2005–06 to 2008–09
    14. Patient risk factors 
      • 14.1 Body mass index
      • 14.2 Smoking (patients aged 18 years and over)
      • 14.3 Alcohol consumption (patients aged 18 years and over)
      • 14.4 Risk factor profile of adult patients
      • 14.5 Changes in patient risk factors over the decade 1999–00 to 2008–09
    15. SAND abstracts and research tools 
      • SAND abstract number 122: Hypertension and use of combination products in general practice patients
      • SAND abstract number 123: Prevalence and management of migraine among general practice patients
      • SAND abstract number 124: Weight loss attempts among general practice patients
      • SAND abstract number 125: Oral corticosteroid use and osteoporosis
      • SAND abstract number 126: Asthma and allergic rhinitis in general practice patients
      • SAND abstract number 127: Chronic pain in general practice patients
      • SAND abstract number 128: Chronic kidney disease among general practice patients
      • SAND abstract number 129: Asthma in general practice patients
      • SAND abstract number 130: Diabetes Type 2 and dyslipidaemia in general practice patients
      • SAND abstract number 131: Prevalence and management of migraine
      • SAND abstract number 132: Prevalence and patterns of multimorbidity
      • SAND abstract number 133: Generic medication substitution for general practice patients
      • SAND abstract number 134: Antipsychotic medication use in general practice patients
      • SAND abstract number 135: Diabetes in general practice patients
      • SAND abstract number 136: Depressive disorders in general practice patients
      • SAND abstract number 137: Osteoporosis in general practice patients
      • SAND abstract number 138: Dyslipidaemia in general practice patients
      • SAND abstract number 139: Secondary prevention of heart attack and stroke
      • SAND abstract number 140: Atrial fibrillation/flutter in general practice patients
      • SAND abstract number 141: Smoking cessation attempts and methods used by general practice patients
      • SAND abstract number 142: Depression and antidepressant use in general practice patients
  • End matter 
    • References
    • Glossary
    • Appendices
      1. Example of a 2008–09 recording form
      2. GP characteristics questionnaire,2008–09
      3. Dissemination of results from the BEACH program
      4. Code groups from ICPC-2 andICPC-2 PLUS
      5. Chronic code groups from ICPC-2 and ICPC-2 PLUS
    • List of tables
    • List of figures